Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.

Journal of Controlled Release(2020)

引用 42|浏览55
暂无评分
摘要
Unlabelled Image
更多
查看译文
关键词
Nanobody,Photodynamic therapy,Fluorescence imaging,HER2-positive breast cancer,Trastuzumab-resistant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要